ClinicalTrials.Veeva

Menu

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Lilly logo

Lilly

Status and phase

Completed
Phase 4

Conditions

Impotence

Treatments

Drug: tadalafil
Drug: sildenafil

Study type

Interventional

Funder types

Industry

Identifiers

NCT00547352
H6D-KL-S002
9152

Details and patient eligibility

About

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

Enrollment

160 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of erection problems
  • Anticipate a monogamous female sexual relationship
  • Abstain from other erection treatments throughout the study
  • Currently use sildenafil

Exclusion criteria

  • Other primary sexual disorders
  • History of radical prostatectomy or other pelvic surgery that affected being able to have an erection
  • History of penile implant or clinically significant penile deformity.
  • Nitrate use
  • Certain heart problems

Trial design

160 participants in 2 patient groups

1
Active Comparator group
Description:
sildenafil treatment for at least 10 weeks prior to a 1 week wash out
Treatment:
Drug: sildenafil
2
Active Comparator group
Description:
Tadalafil treatment for 8 weeks following the 1 week washout period.
Treatment:
Drug: tadalafil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems